Bucheon-si, South Korea

Cheol Min Kim


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cheol Min Kim - Innovator in Hepatitis B Virus Research

Introduction

Cheol Min Kim is a distinguished inventor based in Bucheon-si, South Korea. With a keen focus on biotechnology and virology, he has made significant contributions to the field of hepatitis B virus research.

Latest Patents

Cheol Min Kim holds one patent entitled "Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus." This innovative invention addresses the challenges posed by existing vaccines and therapies, as it introduces an epitope produced in a three-dimensional structure. As a result, this epitope does not induce escape mutations commonly associated with current vaccine formulations or hepatitis B immunoglobulin (HBIg) treatments. His invention's potential as a therapeutic or preventive measure against HBV is noteworthy, given its low likelihood of causing a decrease in efficacy due to such mutations.

Career Highlights

Currently, Cheol Min Kim is associated with Celltrion Inc., a prominent company known for its advancements in biopharmaceuticals. His expertise and innovative approach have positioned him as a valuable asset in the organization, contributing to groundbreaking research and development in the biotechnological landscape.

Collaborations

Throughout his career, Cheol Min Kim has worked closely with colleagues such as Joon Sun Yoon and Hwa Jin Lee. This collaborative environment fosters innovation, allowing them to share ideas and enhance research outcomes, particularly in the realm of hepatitis B virus and other viral diseases.

Conclusion

Cheol Min Kim's contributions to the field of hepatitis B virus research exemplify the importance of innovation in healthcare. His patent highlights a significant step forward in the quest for more effective vaccines and therapies. With continued collaboration and research, his work has the potential to make a profound impact in the prevention and treatment of HBV, ultimately benefiting patients around the world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…